Fig. 7From: Diverse proteins aggregate in mild cognitive impairment and Alzheimer’s disease brainAltered levels of secondary protein modifications in AD brain pelletome. Western blots and quantifications of protein secondary modifications. a Carboxymethyl-lysine (CML). b Advanced glycation end products (AGE). c Methylglyoxal (MG). d 4-hydroxynonenal (HNE). e Ubiquitin. f Acetyl-lysine (AcLys). P values are given. Data are presented as mean ± SEM (n = 8/group)Back to article page